Identifying new targets in pain, utilizing the novel analgesic AS1

利用新型镇痛药 AS1 确定疼痛的新靶点

基本信息

  • 批准号:
    10117446
  • 负责人:
  • 金额:
    $ 39.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-01 至 2025-11-30
  • 项目状态:
    未结题

项目摘要

Project Summary Pain is the number one reason patients seek health care and greater than 20% of the US population is affected by chronic pain. Existing therapeutics have limited efficacy and a narrow therapeutic period, while also evoking deleterious side effects. It is therefore vital to understand pain processing in order to develop novel therapeutics to address this pressing health care crisis. According to the International Association for the Study of Pain (IASP) pain is “an unpleasant sensory and emotional experience associated with actual or potential tissue damage”. Intrinsic to the emotional suffering elicited by pain perception is the attribution of a negative valence to nociceptive stimuli. Dysregulation of aversive motivational circuits may underlie much of the suffering associated with chronic pain conditions. Hedonic valence is a measurement of the intrinsic attractiveness (positive) or averseness (negative) of a stimulus. Pain typically has a negative valence, which is normally advantageous, driving self-protective behavior. Perversely, humans can sometimes assign a positive valence to nociceptive stimuli; think pleasure from spicy foods. This implies that the neural circuits that assign negative valence to nociceptive stimuli are malleable and that pain and aversion can be decoupled. Critically, there have been limited tools to investigate how valence is assigned to nociceptive stimuli by the nervous system. Here, we propose to investigate the effects on nociceptive processing by Analgesic Screen 1 (AS1), a small molecule we discovered that reverses the hedonic motivation (movement toward or away from) of nociceptive stimuli including heat and the noxious chemical allyl isothiocyanate (AITC) in larval zebrafish, rendering these highly aversive stimuli attractive or rewarding in a dose dependent manner. Remarkably, AS1 can tune the valence of nociceptive stimuli, transforming the valence from aversive to neutral to attractive. AS1 has no previously identified target or function. We hypothesize that AS1 potentiates the activity of the dopamine reward system via D1 receptor activation by promoting release of dopamine in the presence of nociceptive stimuli. Experiments in this proposal will make use of the unique advantages of the zebrafish and mouse model systems to test these hypotheses and when completed, we will have characterized the effects of AS1 on nociception and identified upon which neural circuits AS1 acts to invert the valence of nociceptive stimuli from aversive to attractive. In Aim 1, we propose to determine the effects of AS1 on aversion evoked by nociceptive and other aversive stimuli and how these stimuli alter neuronal activity in the CNS in the presence or absence of AS1 in zebrafish. In Aim 2, we will use a comprehensive genetic approach to assess the role of D1 receptor dependent dopaminergic signaling on aversion elicited by nociceptive stimuli in the presence or absence of AS1 in zebrafish. In Aim 3, we will ascertain the effect of AS1 on nociception, place aversion, whether these effects are dependent on D1 receptor activation and where AS1 effects neuronal activity in the CNS in response to nociceptive stimuli using the mouse model system.
项目摘要 疼痛是患者寻求医疗保健的首要原因,超过20%的美国人口受到影响 慢性疼痛。现有的治疗方法具有有限的功效和狭窄的治疗期,同时也引起了对患者的不良反应。 有害的副作用因此,了解疼痛过程以开发新的 来解决这一紧迫的医疗危机。根据国际研究协会(International Association for the Study) 疼痛(IASP)疼痛是“与实际或潜在的疼痛相关的不愉快的感觉和情感体验”。 组织损伤”。由疼痛感知引起的情感痛苦的内在原因是消极的归因。 对伤害性刺激的效价。厌恶性动机回路的失调可能是大部分 与慢性疼痛状况相关的痛苦。快乐价是一种内在的 刺激的吸引力(积极)或厌恶(消极)。疼痛通常具有负效价, 通常是有利的,驱动自我保护行为。也许,人类有时可以将一个积极的 对伤害性刺激的效价;认为辛辣食物带来的快乐。这意味着分配的神经回路 对伤害性刺激的负效价是可延展的,并且疼痛和厌恶可以分离。重要的是, 研究神经系统如何将效价分配给伤害性刺激的工具有限, 系统在这里,我们建议调查镇痛筛选1(AS 1)对伤害性加工的影响, 小分子,我们发现,扭转享乐动机(运动走向或远离)的 伤害性刺激包括热和有害化学物质异硫氰酸烯丙酯(AITC)在斑马鱼幼虫中, 使这些高度厌恶的刺激以剂量依赖的方式具有吸引力或有益。值得注意的是,AS 1 可以调节伤害性刺激的效价,将效价从厌恶转变为中性,再转变为吸引。AS1 没有预先确定的目标或功能。我们假设AS 1增强了 多巴胺奖赏系统通过D1受体激活,在存在多巴胺的情况下促进多巴胺的释放, 伤害性刺激这项提案的实验将利用斑马鱼的独特优势, 小鼠模型系统来测试这些假设,当完成时,我们将表征 AS 1对伤害感受的影响,并确定了AS 1在哪些神经回路上起作用以逆转伤害感受的效价。 从厌恶到吸引的刺激。在目的1中,我们提出确定AS 1对由以下引起的厌恶的影响: 伤害性和其他厌恶性刺激,以及这些刺激如何改变中枢神经系统中的神经元活动, 或在斑马鱼中不存在AS 1。在目标2中,我们将使用全面的遗传方法来评估 D1受体依赖性多巴胺能信号传导对存在或不存在伤害性刺激时由伤害性刺激引起的厌恶的影响 在斑马鱼中没有AS 1。在目标3中,我们将确定AS 1对伤害性感受,位置厌恶, 这些作用是否依赖于D1受体激活,以及AS 1在何处影响脑内神经元活动。 使用小鼠模型系统的CNS对伤害性刺激的响应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AJAY K DHAKA其他文献

AJAY K DHAKA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AJAY K DHAKA', 18)}}的其他基金

Identifying new targets in pain, utilizing the novel analgesic AS1
利用新型镇痛药 AS1 确定疼痛的新靶点
  • 批准号:
    10307581
  • 财政年份:
    2020
  • 资助金额:
    $ 39.63万
  • 项目类别:
Identifying new targets in pain, utilizing the novel analgesic AS1
利用新型镇痛药 AS1 确定疼痛的新靶点
  • 批准号:
    10547775
  • 财政年份:
    2020
  • 资助金额:
    $ 39.63万
  • 项目类别:
A Highthroughput Targeted Genetic Screen for Modulators of Nociception
伤害感受调节剂的高通量靶向遗传筛选
  • 批准号:
    9582710
  • 财政年份:
    2018
  • 资助金额:
    $ 39.63万
  • 项目类别:
An unbiased highthroughput behavior based screen for small molecule analgesics
基于无偏倚高通量行为的小分子镇痛药筛选
  • 批准号:
    9241451
  • 财政年份:
    2016
  • 资助金额:
    $ 39.63万
  • 项目类别:
An unbiased highthroughput behavior based screen for small molecule analgesics
基于无偏倚高通量行为的小分子镇痛药筛选
  • 批准号:
    9090664
  • 财政年份:
    2016
  • 资助金额:
    $ 39.63万
  • 项目类别:
A genetic screen for modulators of nociception
伤害感受调节剂的基因筛选
  • 批准号:
    8670722
  • 财政年份:
    2013
  • 资助金额:
    $ 39.63万
  • 项目类别:
A genetic screen for modulators of nociception
伤害感受调节剂的基因筛选
  • 批准号:
    8546557
  • 财政年份:
    2013
  • 资助金额:
    $ 39.63万
  • 项目类别:
A genetic screen for modulators of nociception
伤害感受调节剂的基因筛选
  • 批准号:
    9063522
  • 财政年份:
    2013
  • 资助金额:
    $ 39.63万
  • 项目类别:
Molecular Characterization of ANKTM1
ANKTM1 的分子表征
  • 批准号:
    6885293
  • 财政年份:
    2005
  • 资助金额:
    $ 39.63万
  • 项目类别:
Molecular Characterization of ANKTM1
ANKTM1 的分子表征
  • 批准号:
    7069145
  • 财政年份:
    2005
  • 资助金额:
    $ 39.63万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.63万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了